Entera Stock Future Price Prediction


USD 1.45  0.06  3.97%   

Entera Bio stock price prediction is an act of determining the future value of Entera Bio shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Entera Bio's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Entera Bio and does not consider all of the tangible or intangible factors available from Entera Bio's fundamental data. We analyze noise-free headlines and recent hype associated with Entera Bio, which may create opportunities for some arbitrage if properly timed.
Continue to Entera Bio Basic Forecasting Models to cross-verify your projections.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Entera Bio based on different types of headlines from major news networks to social media. The Entera stock price prediction module provides an analysis of price elasticity to changes in media outlook on Entera Bio over a specific investment horizon.
EPS Estimate Current Year
EPS Estimate Next Year
Wall Street Target Price
EPS Estimate Current Quarter
Quarterly Revenue Growth YOY
Using Entera Bio hype-based prediction, you can estimate the value of Entera Bio from the perspective of Entera Bio response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Entera Bio using Entera Bio's options and short interest. It helps to benchmark the overall future attitude of investors towards Entera using crowd psychology based on the activity and movement of Entera Bio's stock price.
Entera Bio Asset Turnover is fairly stable at the moment as compared to the past year. Entera Bio reported Asset Turnover of 0.022 in 2021. Book Value per Share is likely to rise to 0.93 in 2022, whereas Current Ratio is likely to drop 6.82 in 2022.

Entera Bio Implied Volatility

Entera Bio's implied volatility exposes the market's sentiment of Entera Bio stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Entera Bio's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Entera Bio stock will not fluctuate a lot when Entera Bio's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Entera Bio. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Entera Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying Entera because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Entera Bio after-hype prediction price

  $ 1.65  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Entera Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Entera Bio in the context of predictive analytics.
LowReal ValueHigh
LowNext ValueHigh
2 Analysts
LowTarget PriceHigh
Estimates (2)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Entera Bio. Your research has to be compared to or analyzed against Entera Bio's peers to derive any actionable benefits. When done correctly, Entera Bio's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Entera Bio.

Entera Bio After-Hype Price Prediction Density Analysis

As far as predicting the price of Entera Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Entera Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Entera Bio, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Entera Bio Estimiated After-Hype Price Volatility

In the context of predicting Entera Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Entera Bio's historical news coverage. Entera Bio's after-hype downside and upside margins for the prediction period are 0.08 and 6.99, respectively. We have considered Entera Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 1.45
After-hype Price
Entera Bio is risky asset. Analysis and calculation of next after-hype price of Entera Bio is based on 3 months time horizon.

Entera Bio Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Entera Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Entera Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Entera Bio, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.84  5.34  0.14   0.00  4 Events / Month1 Events / MonthIn about 4 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Entera Bio Hype Timeline

Entera Bio is currently traded for 1.45. The entity has historical hype elasticity of 0.14 and average elasticity to hype of competition of 0.0. Entera is anticipated to increase in value after the next headline with price projected to jump to 1.65 or above. The average volatility of media hype impact on the company stock price is over 100%. The price jump on the next news is forecasted to be 9.27% whereas the daily expected return is currently at -0.84%. The volatility of related hype on Entera Bio is about 0.0% with expected price after next announcement by competition of 1.45. Entera Bio has return on total asset (ROA) of (42.77) % which means that it has lost $42.77 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (81.04) %, meaning that it created substantial loss on money invested by shareholders. Entera Bio management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities. Return on Invested Capital is likely to rise to 5.50 in 2022, whereas Return on Average Assets are likely to drop (0.51)  in 2022. Entera Bio Assets Non Current are fairly stable at the moment as compared to the past year. Entera Bio reported Assets Non Current of 658,000 in 2021. Goodwill and Intangible Assets is likely to rise to about 556.5 K in 2022, whereas Total Assets are likely to drop slightly above 21.9 M in 2022. Given the investment horizon of 90 days the next anticipatedpress releasewill be in about 4 days.
Continue to Entera Bio Basic Forecasting Models to cross-verify your projections.

Entera Bio Related Hype Analysis

Having access to credible news sources related to Entera Bio's direct competition is more important than ever and may enhance your ability to predict Entera Bio's future price movements. Getting to know how Entera Bio rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Entera Bio may potentially react to the hype associated with one of its peers.
At Risk
PLSQFPlus500 0.00 4 per month 0.00  0.53  0.00  0.00  2.47 

Entera Bio Additional Predictive Modules

Most predictive techniques to examine Entera price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Entera using various technical indicators. When you analyze Entera charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Entera Bio Predictive Indicators

The successful prediction of Entera Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Entera Bio, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Entera Bio based on analysis of Entera Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Entera Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Entera Bio's related companies.

Story Coverage note for Entera Bio

The number of cover stories for Entera Bio depends on current market conditions and Entera Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Entera Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Entera Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Entera Bio Short Properties

Entera Bio's future price predictability will typically decrease when Entera Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Entera Bio often depends not only on the future outlook of the potential Entera Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Entera Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out0.50%
Short Percent Of Float0.60%
Float Shares18.38M
Shares Short Prior Month174.76k
Average Daily Volume Last 10 Day48.79k
Average Daily Volume In Three Month37.82k
Date Short Interest29th of April 2022
Continue to Entera Bio Basic Forecasting Models to cross-verify your projections. Note that the Entera Bio information on this page should be used as a complementary analysis to other Entera Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bond Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for Entera Stock analysis

When running Entera Bio price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Is Entera Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Entera Bio. If investors know Entera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Entera Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
43.5 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Entera Bio is measured differently than its book value, which is the value of Entera that is recorded on the company's balance sheet. Investors also form their own opinion of Entera Bio's value that differs from its market value or its book value, called intrinsic value, which is Entera Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Entera Bio's market value can be influenced by many factors that don't directly affect Entera Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Entera Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Entera Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Entera Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.